Wenger Plattner

Wenger Plattner advised AG Capital on the deal AG Capital, an independent investment firm based in Vienna, has partnered with Layenberger Nutrition Group GmbH, a leading...

Wenger Plattner advises Linear Capital. Linear Capital acted as lead investor on all Swiss legal aspects in the seed round of Swiss-Mile Robotics AG. Swiss-Mile Robotics...

Wenger Plattner advised Normet Group. Normet continues to invest in electrification technology and becomes a minority shareholder of Switzerland-based Motics. Normet has made an equity investment...

Lenz & Staehelin has advised Nordic BioSite Group in this acquisition; Wenger Plattner acted for LubioScience. Nordic BioSite Group, a portfolio company of Adelis Equity Partners, has acquired LubioScience,...

Wenger Plattner advises HG COMMERCIALE on the acquisition of GL Baumaterialhandel GmbH. The team was led by Oliver Künzler (picture). Markus Muehlemann, Benjamin Dürig, André S....

Wenger Plattner Team has advised WSD in the deal. WSD, a structured products software provider, backed by Bowmark Capital, a leading private equity investment firm specialising in...

Wenger Plattner advised Bachem on the deal. Bachem announced the signing of a new framework agreement with an undisclosed customer to provide large volumes of peptides...

Wenger Plattner advised Bachem Group on the deal. Bachem Group (SIX: BANB) announced the acquisition of construction land with a total acreage of up to 155’000...

MLL Legal advised EIM Group on the deal. Wenger Plattner advised Omnes. EIM acquired a minority interest in the group, to support its goal of reinforcing its...

Linklaters and Wenger Plattner supported Audi in relation to its entry into Formula 1 and selection of its strategic partner. As announced by Audi, the premium...

Luther, WengerPlattner and PRK Partner advised Matthews International Corporation on the deal. Matthews International Corporation acquired German based engineering firms, OLBRICH GmbH and R+S Automotive GmbH. OLBRICH...

Wenger Plattner advised Bachem on the deal. Bachem (SIX: BANB) announced a strategic collaboration with Eli Lilly and Company to develop and manufacture active pharmaceutical ingredients...